Analysis of Risk Factors and Protective Strategies for Tube Blockage in Patients with Drug-Induced Liver Failure Based on Artificial Liver Therapy

Objective. To analyse the influencing factors of tube blockage during the treatment of artificial liver in patients with drug-induced liver failure and explore effective patient protection strategies. Methods. In this study, 49 patients with pharmacological (antituberculosis drugs, antibiotics, prop...

Full description

Saved in:
Bibliographic Details
Published in:Evidence-based complementary and alternative medicine 2023, Vol.2023 (1), p.8201776-8201776
Main Authors: Shen, Yan, Shi, Liping, Deng, Luxi, Zhao, Xiaoling
Format: Article
Language:English
Subjects:
Antibiotics
Apheresis
Catheters
Disease
Drugs
Liver
Liver failure
Medical prognosis
Patients
Plasma
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To analyse the influencing factors of tube blockage during the treatment of artificial liver in patients with drug-induced liver failure and explore effective patient protection strategies. Methods. In this study, 49 patients with pharmacological (antituberculosis drugs, antibiotics, proprietary Chinese medicine, gastric drugs, and antihyperthyroid drugs) liver failure admitted to our hospital from June 2015 to December 2021 were selected for prospective analysis. Clinical indicators and general data of all patients were collected and collated, risk factors leading to the obstruction of artificial liver treatment were analysed, and corresponding protective measures were proposed. Results. The incidence of tube blockage was 5.32% (10 times) in 49 patients with pharmacological liver failure treated 188 times with artificial liver therapy. The incidence of tube blockage was significantly higher in patients in the PDF mode than in those in the PP and PE modes (P
ISSN:1741-427X
1741-4288
DOI:10.1155/2023/8201776